1.
Clin Infect Dis
; 66(7): 1116-1119, 2018 03 19.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29272362
RESUMO
For decades, intravenous immunoglobulin (IVIg) has provided safe and effective therapy for immunodeficient patients. This proof-of-principle study describes a novel approach to generate personalized IVIg for chronic, antibiotic-resistant infection in real time.